Mesenchymal Cell News Volume 7.46 | Nov 24 2015

    0
    22

    Mesenchymal Cell News 7.46 November 24, 2015

    Mesenchymal Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  MESCN on Twitter

     
    TOP STORY
    New Approach to Help Bones Heal Faster and Better
    Using bone samples from people undergoing hip replacement surgery, researchers were able to show that a new drug – a protein that activates a molecular pathway called the ‘Wnt’ pathway – causes stem cells found within bones to divide and to turn into more bone cells. [Press release from The University of Southampton discussing online publication in Stem Cell] Press Release | Video | Abstract
    MesenCultâ„¢-ACF: The First Complete, Animal Component-Free MSC Isolation & Culture System FREE Sample Requst

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    IN VITRO

    Cardiac Mesenchymal Stromal Cells Are a Source of Adipocytes in Arrhythmogenic Cardiomyopathy
    The authors investigated whether cardiac mesenchymal stromal cells contributed to excess adipocytes in patients with arrhythmogenic cardiomyopathy (ACM). They found that, in ACM patients’ explanted heart sections, cells actively differentiating into adipocytes are of mesenchymal origin. [Eur Heart J] Full Article

    Influence of Age on Rat Bone-Marrow Mesenchymal Stem Cells Potential
    Six age groups from bone marrow mesenchymal stem cells of Wistar rats were studied (newborn, infant, young, pre-pubertal, pubertal and adult). Quantitative proteomic assay was performed by iTRAQ using an eight-plex iTRAQ labeling and the proteins differentially expressed were grouped in pluripotency, proliferative and metabolism processes. [Sci Rep] Full Article

    Osteogenesis of Peripheral Blood Mesenchymal Stem Cells in Self Assembling Peptide Nanofiber for Healing Critical Size Calvarial Bony Defect
    Peripheral blood mesenchymal stem cells (PBMSCs) were seeded into a nanofiber scaffold of self-assembling peptide (SAP) and cultured in osteogenic medium. The results indicated SAP can serve as a promising scaffold for PBMSCs survival and osteogenic differentiation in 3D conditions. [Sci Rep] Full Article

    Early Passage Dependence of Mesenchymal Stem Cell Mechanics Influences Cellular Invasion and Migration
    For clinical applicability during stem cell migration in vivo, scientists investigated the ability of human mesenchymal stem cells to invade into micropillar arrays of increasing confinement from 12 to 8 μm spacing between adjacent micropillars. [Ann Biomed Eng] Abstract

    Protective Effects of HGF Gene-Expressing Human Mesenchymal Stem Cells in Acetaminophen-Treated Hepatocytes
    The authors investigated the protective effect of hepatocyte growth factor (HGF) gene-transfected mesenchymal stem cells (MSCs) in acetaminophen-treated hepatocytes. They transfected the HGF gene into MSCs and confirmed HGF expression by RT-PCR and western blot. [Growth Factors] Abstract

    CD4+ T Cells from Patients with Acute Myeloid Leukemia Inhibit the Proliferation of Bone Marrow-Derived Mesenchymal Stem Cells by Secretion of miR-10a
    Through co-culturing CD4+ T cells from acute myeloid leukemia patients and bone marrow-derived mesenchymal stem cells (BM-MSCs) from healthy, investigators detected the proliferation of BM-MSCs from healthy by MTT assay. [J Cancer Res Clin Oncol] Abstract

    IN VIVO

    Tracking and Therapeutic Value of Human Adipose Tissue-Derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula
    Researchers aimed to determine if adventitial transplantation of human adipose tissue-derived mesenchymal stem cells to the outflow vein of B6.Cg-Foxn1nu/J mice with arteriovenous fistula at the time of creation would reduce monocyte chemoattractant protein-1 gene expression and venous neointimal hyperplasia. [Radiology] Abstract

    PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries
    Investigators evaluated the efficacy of combination intravenous mesenchymal stem cells and parathyroid hormone (PTH) therapy versus monotherapy and untreated controls, in a rat model of osteoporotic vertebral bone defects. [Mol Ther] Abstract

    Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy
    Bone marrow-derived mesenchymal stem cells were indirectly cocultured with neonatal rat ventricular cardiomyocytes in vitro or intramyocardially transplanted into hypertrophic hearts in vivo. [Stem Cells Transl Med] Abstract

    Propranolol and Mesenchymal Stromal Cells Combine to Treat Traumatic Brain Injury
    Given the nonredundancy in their therapeutic mechanisms, investigators hypothesized that a combination of acute propranolol followed by mesenchymal stem cells isolated from human bone marrow would have additive effects in treating a rodent model of traumatic brain injury. [Stem Cells Transl Med] Abstract

    NEW: Animal Component-Free MSC Chondrogenic Differentiation. Learn More.

     
    REVIEWS
    Spheroid Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Microvesicles: Two Potential Therapeutic Strategies
    The characteristics, therapeutic applications and potential clinical translational opportunities of spheroid mesenchymal stem cells (MSCs) and MSC-microvesicles were discussed. [Stem Cells Dev] Abstract

    Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.

    Register for Clinical Applications of Stem Cells 2016

     
    INDUSTRY NEWS
    BioRestorative Therapies Granted Key Metabolic Patent
    BioRestorative Therapies, Inc. announced the United States Patent and Trademark Office has issued a US patent covering methods related to BRT’s metabolic program. The patent allows for the protection of methods of production of generating stem cells and stem cell lines from brown adipose tissue under xeno-free conditions utilizing a proprietary differentiating medium. [BioRestorative Therapies, Inc.] Press Release

    Nova Southeastern University Announces New NSU Cell Therapy Institute, an International Biomedical Research Collaboration with Scientists from the World-Renowned Karolinska Institutet
    Nova Southeastern University (NSU) is at the forefront of conducting pioneering cell-based biomedical research with the launch of the new NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from Karolinska Institutet. [Nova Southeastern University (PR Newswire Association LLC)] Press Release

    From our sponsor:
    Discover how to reduce variability in primary neuron cultures with NeuroCult™ SM.
    Watch the webinar.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Keystone Symposium – Molecular and Cellular Basis of Growth and Regeneration
    January 10-14, 2016
    Breckenridge, United States

    Visit our events page to see a complete list of events in the mesenchymal cell community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Position – Adipose Stromal Cells (University of Texas Health Science Center at Houston)

    NEW Postdoctoral Position – Organogenesis and Mesenchymal Stem Cells (University of Southern California)

    Postdoctoral Fellows – Cardiovascular Biology and Regenerative Medicine (Icahn School of Medicine at Mount Sinai)

    Faculty Positions – Stem Cell Biology (Albert Einstein College of Medicine)

    Research Technician II – Stem Cell and Gene Therapy (Fred Hutchinson Cancer Research Center)

    Assistant or Associate Professor – Cell and Regenerative Biology (University of Wisconsin – Madison)

    Postdoctoral Positions – Regenerative Biology and Medicine (Helmholtz Association)

    Postdoctoral Fellowship – Developmental Cell Biology and Regenerative Medicine (University of California San Francisco)

    Postdoctoral Position – Bone Research (Weill Cornell College of Medicine)

    Postdoctoral Fellow/Research Associate – Leukemia, Stem Cells and Development (Josep Carreras Leukemia Research Institute)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Mesenchymal Cell News: Archives | Events | Contact Us